Survival in Acute Myocardial Infarction
... during the first 4 hours of the initiation of symptoms, survival is improved even to a period of 12 years (19). The benefits of its use are enhanced when it is associated with the administration of ASA and beta blockers and above all with its early and sustained administration during the years follo ...
... during the first 4 hours of the initiation of symptoms, survival is improved even to a period of 12 years (19). The benefits of its use are enhanced when it is associated with the administration of ASA and beta blockers and above all with its early and sustained administration during the years follo ...
Yang ZH, Madinova A, Kozai T, Joch H, Aebi U, Luscher TF
... This review discusses the treatment options available for uncomplicated arterial hypertension and compares monotherapy with combination therapy for control of this condition. The current recommendation for the treatment of uncomplicated hypertension is mono-drug therapy involving stepwise dose incre ...
... This review discusses the treatment options available for uncomplicated arterial hypertension and compares monotherapy with combination therapy for control of this condition. The current recommendation for the treatment of uncomplicated hypertension is mono-drug therapy involving stepwise dose incre ...
ACLS Study Guide Cover 11-09-06.ai
... Vital Signs: Vital signs provide a diagnostic evaluation of the patient. Blood Pressure is the primary indicator. A systolic blood pressure above 90 mm usually indicates that the patient is stable (although the provider should be alert for changes in blood pressure that might indicate an unstable pa ...
... Vital Signs: Vital signs provide a diagnostic evaluation of the patient. Blood Pressure is the primary indicator. A systolic blood pressure above 90 mm usually indicates that the patient is stable (although the provider should be alert for changes in blood pressure that might indicate an unstable pa ...
Imaging of hypoplastic left heart syndrome –A rare
... echocardiography play an important role in detecting HLHS prenatally. HLHS can be detected by 18 – 22 weeks of gestation by USG. It is the most common cardiac malformation detected in fetal life .Here we present a case of the second gravida, came for anomaly scan, found to be carrying a fetus with t ...
... echocardiography play an important role in detecting HLHS prenatally. HLHS can be detected by 18 – 22 weeks of gestation by USG. It is the most common cardiac malformation detected in fetal life .Here we present a case of the second gravida, came for anomaly scan, found to be carrying a fetus with t ...
Congestive Heart Failure
... to become progressively worse with time, the disease has been classified according to the severity of symptoms: Class I: No obvious symptoms, no limitations on physical activity. Class II: Some symptoms during or after normal activity, mild physical activity limitations. Class III: Symptoms with les ...
... to become progressively worse with time, the disease has been classified according to the severity of symptoms: Class I: No obvious symptoms, no limitations on physical activity. Class II: Some symptoms during or after normal activity, mild physical activity limitations. Class III: Symptoms with les ...
Arrhythmia Diagnosis and Management
... • QRS: usually widened because this is usually associated with a bundle branch block. • Conduction: P-R interval may be normal or prolonged, but it is constant until one P wave is not conducted to the ventricles. • Rhythm: usually regular when AV conduction ratios are constant • This block usually o ...
... • QRS: usually widened because this is usually associated with a bundle branch block. • Conduction: P-R interval may be normal or prolonged, but it is constant until one P wave is not conducted to the ventricles. • Rhythm: usually regular when AV conduction ratios are constant • This block usually o ...
Registry Proposal - Pediatric and Congenital Electrophysiology
... Though intravenous sotalol has been used outside the US for over thirty years, it was only recently approved by the Food and Drug Administration (FDA; 2009) and reintroduced to the US market (2015). Sotalol is a class III antiarrhythmic agent that prolongs action potential duration while also blocki ...
... Though intravenous sotalol has been used outside the US for over thirty years, it was only recently approved by the Food and Drug Administration (FDA; 2009) and reintroduced to the US market (2015). Sotalol is a class III antiarrhythmic agent that prolongs action potential duration while also blocki ...
MRI GUIDELINES
... on a patient who has the VNS Therapy System. Thus, protocols must not be used that utilize local coils that are RF receive-only, with RF-transmit performed by the body coil. Note that some RF head coils are receive-only, and that most other local coils, such as knee and spinal coils, are also RF-rec ...
... on a patient who has the VNS Therapy System. Thus, protocols must not be used that utilize local coils that are RF receive-only, with RF-transmit performed by the body coil. Note that some RF head coils are receive-only, and that most other local coils, such as knee and spinal coils, are also RF-rec ...
THE INCIDENCE OF ARRYTHMIAS IN PATIENTS UNDERGOING
... patients approx 10 - 15% shows arrhythmia only during exercise testing. The need for AV sequential pacing in selected patients particularly with congenital AV block may be established in those patients who show low heart rate despite exercise and those who developed symptomatic rapid junctional rhyt ...
... patients approx 10 - 15% shows arrhythmia only during exercise testing. The need for AV sequential pacing in selected patients particularly with congenital AV block may be established in those patients who show low heart rate despite exercise and those who developed symptomatic rapid junctional rhyt ...
Nuclear Medicine MUGA Scan
... highly reproducible, meaning if the test is repeated several times, nearly the same answer is always obtained. Along with the noninvasive nature of the test, these advantages make the MUGA scan ideal for detecting subtle changes in cardiac function that could be missed with other techniques. A commo ...
... highly reproducible, meaning if the test is repeated several times, nearly the same answer is always obtained. Along with the noninvasive nature of the test, these advantages make the MUGA scan ideal for detecting subtle changes in cardiac function that could be missed with other techniques. A commo ...
Improving Thromboprophylaxis Using Atrial Fibrillation Diagnostic
... ClinicalService Project. This national cardiovascular data repository and medical care project aims to describe and improve the use of ICDs in Italian clinical practice. The project was approved by each site’s institutional review board or medical director and conforms with the principles outlined i ...
... ClinicalService Project. This national cardiovascular data repository and medical care project aims to describe and improve the use of ICDs in Italian clinical practice. The project was approved by each site’s institutional review board or medical director and conforms with the principles outlined i ...
Is Phonocardiogram Gating a Reliable Alternative to ECG
... Introduction: Similar to other applications of clinical MRI, cardiac MR (CMR) is moving toward imaging at ultrahigh field strengths (≥ 7 Tesla) due to potential gains associated with increasing field strengths. Beside the well-known challenges intrinsically tied to all imaging at ultrahigh field str ...
... Introduction: Similar to other applications of clinical MRI, cardiac MR (CMR) is moving toward imaging at ultrahigh field strengths (≥ 7 Tesla) due to potential gains associated with increasing field strengths. Beside the well-known challenges intrinsically tied to all imaging at ultrahigh field str ...
Glidepath - Syncope
... Cherin P, Colvez A, Deville de Periere G, Sereni D: Risk of syncope in the elderly and consumption of drugs: A case-control study. J Clin Epidemiol 1997; 50: 313-20. 4. Five referral studies of carotid sinus message in syncope show that its greatest utility may be in older patients (mean age in stud ...
... Cherin P, Colvez A, Deville de Periere G, Sereni D: Risk of syncope in the elderly and consumption of drugs: A case-control study. J Clin Epidemiol 1997; 50: 313-20. 4. Five referral studies of carotid sinus message in syncope show that its greatest utility may be in older patients (mean age in stud ...
Structural Heart Disease Workshop
... 1. Medications – what do you think of the medical regime? Anything missing? 2. Take note of the pattern of blood pressure response to exercise. What does that suggest to you? 3. A "non-homogenous distribution of radionuclide tracer" is reported. What are they saying here? 4. The echocardiogram repor ...
... 1. Medications – what do you think of the medical regime? Anything missing? 2. Take note of the pattern of blood pressure response to exercise. What does that suggest to you? 3. A "non-homogenous distribution of radionuclide tracer" is reported. What are they saying here? 4. The echocardiogram repor ...
Transthoracic echocardiography for the evaluation of pulmonary
... Early pulmonary insufficiency peak gradient4 Not applicable in severe pulmonary regurgitation Doppler studies need to be performed carefully to obtain best and complete flow signals (Doppler interrogation parallel to flow, mean of 3 end-expiratory values) Assessment of RV function TAPSE/TAM TDI syst ...
... Early pulmonary insufficiency peak gradient4 Not applicable in severe pulmonary regurgitation Doppler studies need to be performed carefully to obtain best and complete flow signals (Doppler interrogation parallel to flow, mean of 3 end-expiratory values) Assessment of RV function TAPSE/TAM TDI syst ...
Coalition 167 – Reducing readmissions for heart failure patients
... The Coalition has included an estimate for 2018-19 of $0.1 million. DTF has undertaken a costing of this figure and considers $0.1 million to be a reasonable estimate for 2018-19 and notes that this would bring the total estimated cost of the proposal to $0.4 million over five years. DTF comments se ...
... The Coalition has included an estimate for 2018-19 of $0.1 million. DTF has undertaken a costing of this figure and considers $0.1 million to be a reasonable estimate for 2018-19 and notes that this would bring the total estimated cost of the proposal to $0.4 million over five years. DTF comments se ...
Hemodynamic Monitoring
... Starling’s Law= greater the stretch of muscle fibers, the greater the force of contraction and volume of blood ejected. increased contractility due to sympathetic stimulation ie drugs (dig, dopamine, dobutamine, epinephrine, calcium) decreased contractility due to loss of myocardial function as ...
... Starling’s Law= greater the stretch of muscle fibers, the greater the force of contraction and volume of blood ejected. increased contractility due to sympathetic stimulation ie drugs (dig, dopamine, dobutamine, epinephrine, calcium) decreased contractility due to loss of myocardial function as ...
This is the new PowerPoint template
... Indicated for CRT, with QRS duration >130 ms, and planned to be implanted with a market-released Medtronic CRT device with AdaptivCRT and a Medtronic quadripolar lead Meets at least one of the following criteria QRS duration < 150 ms Prior documented Myocardial Infarction Non-LBBB Exclusio ...
... Indicated for CRT, with QRS duration >130 ms, and planned to be implanted with a market-released Medtronic CRT device with AdaptivCRT and a Medtronic quadripolar lead Meets at least one of the following criteria QRS duration < 150 ms Prior documented Myocardial Infarction Non-LBBB Exclusio ...
Evaluation of Native Left Ventricular Function During Mechanical
... failure, and showed rapid and complete recovery of LV function during mechanical support1), and I estimate that the current recovery rate has increased to about 5%. Although precise evaluation of the native left ventricle is very important when weaning a patient from LVAD support, the commonly used ...
... failure, and showed rapid and complete recovery of LV function during mechanical support1), and I estimate that the current recovery rate has increased to about 5%. Although precise evaluation of the native left ventricle is very important when weaning a patient from LVAD support, the commonly used ...
Outpatient Cardiovascular Telemetry
... (3%), cardioverter defibrillator implanted (2%), anticoagulation stopped (2%), pacemaker replaced (1%), and drug treatment stopped (1%). Although these treatment changes were designed to address specific findings of cardiac monitoring, this study did not involve any subsequent monitoring or follow-u ...
... (3%), cardioverter defibrillator implanted (2%), anticoagulation stopped (2%), pacemaker replaced (1%), and drug treatment stopped (1%). Although these treatment changes were designed to address specific findings of cardiac monitoring, this study did not involve any subsequent monitoring or follow-u ...
ECG Interpretation
... Place the patient in right lateral recumbency. (A rhythm strip can be obtained from any position) Part the hair. Attach the electrodes to the skin just proximal (above) to the elbows and stifles. Wet the electrodes with alcohol (do not soak). If panting or excessive motion, move the front limb leads ...
... Place the patient in right lateral recumbency. (A rhythm strip can be obtained from any position) Part the hair. Attach the electrodes to the skin just proximal (above) to the elbows and stifles. Wet the electrodes with alcohol (do not soak). If panting or excessive motion, move the front limb leads ...
17- interior of heart
... Its walls are 3 times thicker than those of the right ventricle. The left ventricular blood pressure is 6 times higher than that inside the right ventricle. In cross section, the left ventricle is circular, the right is crescentic because of the bulging of the ventricular septum into the cavity of t ...
... Its walls are 3 times thicker than those of the right ventricle. The left ventricular blood pressure is 6 times higher than that inside the right ventricle. In cross section, the left ventricle is circular, the right is crescentic because of the bulging of the ventricular septum into the cavity of t ...
Cardiac contractility modulation
.jpg?width=300)
Cardiac contractility modulation (CCM) is a treatment for patients with moderate to severe left ventricular systolic heart failure (NYHA class II–IV). The short- and long-term use of this therapy enhances both the strength of ventricular contraction and the heart’s pumping capacity. The CCM mechanism is based on stimulation of the cardiac muscle by non-excitatory electrical signals (NES). CCM treatment is delivered by a pacemaker-like device that applies the NES, adjusted to and synchronized with the electrical action in the cardiac cycle.In CCM therapy, electrical stimulation is applied to the cardiac muscle during the absolute refractory period. In this phase of the cardiac cycle, electrical signals cannot trigger new cardiac muscle contractions, hence this type of stimulation is known as a non-excitatory stimulation. However, the electrical CCM signals increase the influx of calcium ions into the cardiac muscle cells (cardiomyocytes). In contrast to other electrical stimulation treatments for heart failure, such as pacemaker therapy or implantable cardioverter defibrillators (ICD), CCM does not affect the cardiac rhythm directly. Rather, the aim is to enhance the heart’s natural contraction (the native cardiac contractility) sustainably over long periods of time. Furthermore, unlike most interventions that increase cardiac contractility, CCM is not associated with an unfavorable increase in oxygen demand by the heart (measured in terms of Myocardial Oxygen Consumption or MVO2). This may be explained by the beneficial effect CCM has in improving cardiac efficiency. A meta-analysis in 2014 and an overview of device-based treatment options in heart failure in 2013 concluded that CCM treatment is safe, that it is generally beneficial to patients and that CCM treatment increases the exercise tolerance (ET) and quality of life (QoL) of patients. Furthermore, preliminary long-term survival data shows that CCM is associated with lower long-term mortality in heart failure patients when compared with expected rates among similar patients not treated with CCM.